13F

Stock

Akari Therapeutics Plc

AKTX · held by 7 managers

Reported value

$308.2K

Holders

7

+7 new · −20 exited

Holders’ est. mark

$289.2K

Price effect on 5 books still in the name

Largest holder

$200.4K

ARMISTICE CAPITAL, LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
ARMISTICE CAPITAL, LLC38.9K$200.4K$189.2KCut−$586.8K
Cresset Asset Management, LLC20.6K$105.9K$99.9KCut−$131.8K
IFP Advisors, Inc7.43K$1.81KNew
SBI Securities Co., Ltd.5$26$25Cut−$32
MORGAN STANLEY1$5$5Added$4
Truvestments Capital LLC1$5$5Cut−$9

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.